Percorrer por autor "Fernandes, Lília"
A mostrar 1 - 2 de 2
Resultados por página
Opções de ordenação
- Biomarker of Chronic Alcohol Abuse – Carbohydrate-deficient Transferrin (CDT): Methodology VerificationPublication . Gomes, Filomena; Costa, Alcina; Fernandes, Lília; Silva, Ana Maria V. da; Vasconcelos, Miguel; Miranda, ArmandinaIntroduction: Transferrin is a glycoprotein synthesized in hepatocytes that can appear with different isomorphic forms in the plasma, acquiring different levels of sialization (1,2). In a healthy person, penta, tetra and trisial isoforms are detectible in plasma. However, in an alcohol abuse and/or dependence, asialo, monosialo and disialotransferrin isoforms are also present called carbohydrate-deficient transferrin (CDT) (3) . This is considered a specific biomarker of alcohol abusive and/or dependence, being useful in the diagnosis and monitoring of this pathology (4) . Aim: Verify compliance with the requirements of the manufacturer of the capillary electrophoresis method in laboratory practice and its suitability in determining the CDT. Materials and methods: The MiniCap System (Sebia) was used with calibrators traceable to the IFCC international reference procedure and normal and pathological internal control samples. Repeatability and intermediate precision tests were performed on control samples. From participation in External Quality Assessment (EQA) program (5 rounds - 2 samples each), Bias%, Deviation Index (DI) and Total Laboratory Error (TELab) were obtained. The Measurement Uncertainty was calculated by the Top Down Method (combined and expanded with a factor of 1.96), using the internal (CV%) and external (Bias%) quality control results. Results: In the repeatability tests, normal control samples (n=22, mean = 1.4%) were obtained, CV = 5.7%; for the pathological sample (n=24, mean = 5.4%), CV = 2.2%. In intermediate precision tests for the normal control sample, (n= 12, mean = 1.4%), CV = 6.7%; for the pathological sample (n=12, mean = 5.3%), CV = 4.9%. In samples from EQA program, mean Bias = -1.0% and TELab = 11.5. In the evaluation of the method by DI, 1 satisfactory, 7 good and 2 excellent results were obtained. The obtained Expanded Uncertainty (1.3% ± 0.3) is consistent with that indicated by the manufacturer. Conclusion: The TELab obtained meets Westgard`s desirable specifications (5) , being considered an appropriate methodology for use in laboratory practise for diagnosis. However, it is considered important to monitor the method with Internal Control samples, and participate in EQA programs, as well as periodic evaluation of Quality Indicators.
- Implementation of Internal Quality Control in Clinical Laboratories of Portuguese Speaking CountriesPublication . Pinto, Mariana; Viegas, Silvia; Miranda, Armandina; Vieira, Cristina; Fernandes, Lília; Constantino, José; Alvim, Marta; Leal, Silvânia; dos Santos, Menilita; Rodrigues, Nádia; da Luz, Maria; Martinello, Flávia; Pimenta, Manuela; Faria, AnaProMeQuaLab (Laboratory Quality Improvement Project for Portuguese Speaking Countries) is an ongoing project started in 2015 aiming to improve the quality of laboratory results in Portuguese Speaking countries ( It focuses on training in laboratory quality control, implementation and monitoring of quality indicators, and the organisation of a biennial congress. In 2023 within the scope of ProMeQuaLab and in collaboration with the National Health Institute Doctor Ricardo Jorge ( and the Faculty of Pharmacy of University of Lisbon, the Master's thesis "Development of tools and documentation for implementation of laboratory Quality Control in Portuguese Speaking countries" is being carried out. AIMS: Development and application tools for implementation of Internal Quality Control in the areas of Clinical Chemistry and Haematology, in PLP laboratories, from February to August 2023